PHG Foundation Deputy Director Dr Philippa Brice has been awarded a Capabilities in Academic Policy Engagement (CAPE) Policy Fellowship to explore issues in precision medicine.
The information held within our genes and how it can be used to improve individual health, continues to generate excitement among researchers, health professionals and policymakers. The potential to routinely use polygenic scores in clinical practice is currently of particular interest, and research indicates that polygenic scores for cardiovascular disease may be the closest to potential…
A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
The abrupt change in Secretary of State for Health for the UK has overshadowed some recent, and very significant, health-relevant policy developments.
Vaccinations against the COVID-19 causing virus began this week after the approval of an mRNA-based vaccine developed by Pfizer/BioNtech. This is the first COVID-19 vaccine approved in the UK and several other countries are reviewing the data.
PHG Foundation's new report outlines opportunities and issues posed by the increasing use of citizen generated data (CGD) to inform health, and especially to improve disease prevention in the UK.
The UK government has launched a new National Genomic Healthcare Strategy intended to secure the country’s future position as a global leader in genomics and create ‘the most advanced genomic healthcare system in the world’.
A PHG Foundation report reveals room for improvement in breast cancer prevention - and calls for action to reduce evidence gaps for risk tools.
Coronavirus SARS-CoV-2, the virus behind the COVID-19 pandemic, has been studied intensely since emerging in late 2019 – so far, researchers have sequenced tens of thousands of SARS-CoV-2 genomes to learn about the genetic variation of the virus.
Project DELTA aims to diagnose up to 50% of cases of oesophageal cancer earlier, leading to improvements in survival, quality of life and economic benefits for the NHS.
New research from the PHG Foundation highlights important issues for the proportionate and effective regulation of genomic data in medical research and healthcare that balance legal protections with utility.
Like other complex algorithms, machine learning can be ‘black box medicine’ - where conclusions (that may influence decisions related to care) are made without users understanding why.
The PHG Foundation has published a new report examining the true potential of AI to deliver genomic medicine. Artificial intelligence for genomic medicine sets out seven policy priorities for decision makers in order to make the best of this potential, while minimsing harms.
Until the coronavirus pandemic took hold, it seemed that at least every other headline about healthcare innovations was related to machine learning or other forms of artificial intelligence (AI) - systems that can mimic human processes such as the capacity to learn and adapt on the basis of new information increasingly used in technology.
PHG Foundation has been awarded recognised supplier status on the NHS Shared Business Services Framework Agreement.
Parliamentary Under Secretary of State for Health Lord O’Shaughnessy has highlighted the vital importance of providing reassurance to the public and promoting the benefits of data sharing for the success of personalised medicine.
The House of Commons Science and Technology Committee has released a major report, Genomics and genome editing in the NHS. The report is the result of its 2017 inquiry, to which Cambridge-based think tank, the PHG Foundation, provided extensive written and oral evidence.
The House of Lords Select Committee on Artificial Intelligence (AI) has published a report urging the UK to take the lead in the ethical development and deployment of AI. The report and subsequent recommendations made to Government have been guided by evidence from a range of experts, including the PHG Foundation.
The vast majority of hospital doctors do not consider themselves qualified or competent to interpret the results of genomic tests.
Genomic medicine is here to stay – but more needs to be done to ensure NHS patients can benefit, was the message coming loud and clear at the conference held by Cambridge health policy think tank, the PHG Foundation, this week. Learning from the genomics experience will be crucial as new technologies come on stream to transform and personalise healthcare delivery, delegates were advised.
Giving evidence on Artificial Intelligence to a House of Lords Select Committee, PHG Foundation's Dr Sobia Raza highlighted the need for an NHS-wide strategy on using health data for algorithm development to realise the benefits of AI for patients.
We are pleased to announce Dr Mark Kroese as the new Director of the PHG Foundation. Mark will be taking over from Dr Hilary Burton, who stepped down as Director at the end of September.
A report published by the PHG Foundation argues that limited awareness of validated ctDNA testing technology is restricting access to targeted therapy in a sub-group of patients with non-small cell lung cancer.
With the Chief Medical Officer's 2017 annual report focusing on genomics, local genomics pioneers, PHG Foundation had plenty to celebrate at their 20th anniversary gala dinner this week.
Personalised healthcare and genomic medicine will be in the spotlight at a Cambridge conference this autumn. Examining the implications of genomics and other technologies on the delivery of healthcare, ‘Healthy futures: genomics and beyond’ on 28 November 2017 is a must for those working at the frontline of healthcare.